An interesting study looking at using a deep learning model to evaluate ECGs in the emergency room to determine if patients need coronary revascularization as existing methods can sometimes be inconclusive. academic.oup.com/eurheartj/ad...

Tomorrow is your last chance to visit this BP measurement learning station at #ACC25! Avoiding common pitfalls is key to accurate care—don’t miss it in the Personalized Skills Center. learn.acc.org/Page/LEARNHTN #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

ALPACA: The novel extended-duration small interfering RNA lepodisiran reduced mean serum concentrations of Lp(a) from 60 to 180 days after being administered subcutaneously. #ACC25 Learn more about the study ➡️ bit.ly/3Y1DkU7 #CardioSky #MedSky

Dr. Victor Dzau presenting his keynote speech, Science, Medicine, and Society: A Brave New World, during the 2025 Eugene Braunwald Keynote happening now! 📍Room S100b #ACC25 #CardioSky

FRESH-UP Trial #ACC25 #medsky RCT comparing liberal vs restricted fluid intake (≤1500 ml/d) in 504 pts with stable chronic HF 🌊No difference in status health quantified by Kansas City Cardiomyopathy Questionnaire at 3 mths 🌊 More thirst distress with restriction www.nature.com/articles/s41...

Dr. Victor Dzau: How do we improve #cvd with rising #obesity? ✅Start with 1° and 2° #cvprev ✅Primordial prevention @accintouch.bsky.social #acc25

Dr. Victor Dzau: Future of #CVD care is going to be evolving rapidly over the next century: ❤️ Emphasis on prevention ❤️ Equitable access and affordable ❤️ Mission-based innovation ❤️ Develop national priorities Need governance to oversee innovation, ensure ethics #acc25 @accintouch.bsky.social

Wellstar team-based care in action at #ACC25! This poster showcases a coordinated strategy to improve SGLT2i use post-AMI—driving better prescribing, education, and follow-up for patients. #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

FRESH-UP at #ACC25: No benefit to fluid restriction in HF. No harm with liberal intake. Improved QOL with more fluid freedom. Supports what we have long suspected—and may help shift the standard of care moving forward. #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

American College of Cardiology@accintouch.bsky.social · 2y ago

Limiting fluid intake may have no benefit for patients with #HeartFailure, according to findings from the FRESH-UP study presented during a Late-Breaking Clinical Trial session at #ACC25. Check out the key findings ➡️ bit.ly/3DYGHEl #CardioSky #MedSky

#ACC25 #LGBTQ work group represents at the Health #Equity Hub! Dr Deb and Dr Coylewright - So proud of the work you’re both doing! @thornsberryjd.bsky.social @brototod.bsky.social

Join us for this exciting session on management of CIEDs in complex patients - #ACC25 #CIED #cardiopalli #SDM @accintouch.bsky.social @thornsberryjd.bsky.social

EquiOx at #ACC25 confirms it: pulse oximeters don’t perform equally across skin tones—especially critically ill patients Wellstar’s, Dr. Paul Douglass shared insight on the need for equity in device validation #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

MIGHTy-Heart took on gaps in HF care transitions. ✴️ 2,003 enrolled → MIH vs. TOCC ✴️ No difference in 30-day outcomes ✴️ Younger patients & women saw more benefit. Impressive representation: 52% women, 47% Black #ACC25 #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

🔥Hot off the press: Highlights from day 1 at #ACC25 #CardioSky 📌 WARRIOR 📌 STRIDE 📌 API-CAT 📌 SOUL 📌 RIVAWAR 📌 & more in the link www.healio.com/news/cardiol...

Among persons with type 2 diabetes and atherosclerotic cardiovascular disease, chronic kidney disease, or both, oral semaglutide was associated with a significantly lower risk of major adverse cardiovascular events than placebo #MedSky #CardioSky #NephSky www.nejm.org/doi/full/10....

Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes | NEJM

The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ca...

nejm.org

More from day 1 #ACC25 … 📌 WARRIOR = the largest study of women with suspected ischemia with nonobstructive coronary disease 📌 Intensive medical therapy did not prevent 🫀 events for women with INOCA 📌 “This trial should not be considered a negative trial” www.healio.com/news/cardiol...

Intensive medical therapy does not help or harm women with chest pain: WARRIOR

CHICAGO — Among women with suspected ischemia with nonobstructive coronary disease, an intensive medical therapy strategy did not reduce risk for major adverse CV events at 5 years compared with...

healio.com

#ACC25 #Palliative Workgroup Huddle! So much creativity and compassion - and WORK - in the this group! #ACCGeriatric #ACCFIT #ACCCVT @accintouch.bsky.social @shummelmd.bsky.social @thornsberryjd.bsky.social

Join us for a fun #CardioObstetrics session at #ACC25 #CardioSky 📅 Sun, Mar 30 ⏰ 10AM @accintouch.bsky.social @mdharringtonc.bsky.social @drklindley.bsky.social @abraguo.bsky.social @garimasharmamd.bsky.social @drmarthagulati.bsky.social @erinmichos.bsky.social @thornsberryjd.bsky.social

Join us now for #ACC25 #CardioObstetrics Meet-Up @accintouch.bsky.social @mdharringtonc.bsky.social @drklindley.bsky.social

Today at 4:30PM Don’t miss #ACC25 #CardioObstetrics Meet-Up

Abra Guo, MD FACC@abraguo.bsky.social · 2y ago

T minus 5 days to #ACC25 🚨🚨🚨 🫀Reprohealth and #Cardioobstetrics member Meet-Up 🫀When: March 29 4:30 CST 🫀Where: Lounge + Learn Pavilion. Zone 2 #cardiosky #medsky #obsky #maternalhealth #reprosky #highriskpregnancy #mfmsky #womensheartdisease @accintouch.bsky.social @acog-org.bsky.social

📆 Mark your calendars for Monday at #ACC25! Wellstar MCG presents a high-stakes case: RotaWire entrapment, fracture, and retrieval—titled “When It Rains It Pours.” ☔️💙 You won’t want to miss this one! #WellstarCVteam #CardioSky @accintouch.bsky.social @jaccjournals.bsky.social

An oral formulation of semaglutide lowered the risk major adverse cardiovascular events by 14% in four years, with no change in safety profile compared to placebo, according to the SOUL study. #ACC25 Read the journal scan to learn more: bit.ly/3QTpizK #CardioSky #MedSky

DAPA-TAVI: The #SGLT2 inhibitor dapagliflozin was superior to standard care alone in decreasing rates of all-cause mortality or worsening #HeartFailure in older adults w/ #vhdAS undergoing TAVI, resulting in a 28% relative risk ↘️. #ACC25 More: bit.ly/4cfLNsy #cvSurg #CardioSky #MedSky

In SOUL, 2596/9650 (26.9%) participants were receiving SGLT2i at baseline (largest CVOT of combined GLP-1/SGLT2 to date) The effect of oral semaglutide on cardiovascular outcomes was consistent, regardless of SGLT2i use #ACC25 www.ahajournals.org/doi/abs/10.1...

#equity in heart care. Yes. ❤️ #ACC25 #ACCCVT

Joshua Thornsberry@thornsberryjd.bsky.social · 2y ago

📸 Dr. Douglass on the big screen at #ACC25! As Chair of the ACC Task Force on Health Equity, his leadership is moving us closer to true equity in heart care. 💙 #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

Learn more about ACC's NP/PA #CCKE: bit.ly/3oOmx80 #ACC25 #CardioSky #MedSky

Certified Cardiovascular Knowledge Examination - For NPs/PAs practicing in the U.S. - American College of Cardiology

Demonstrate your clinical knowledge and commitment to cardiovascular excellence by taking and passing ACC’s Certified Cardiovascular Knowledge Examination (CCKE). Open to NPs/PAs practicing in the U.S...

bit.ly

Joshua Thornsberry@thornsberryjd.bsky.social · 2y ago

Key takeaways from the CCKE for NPs & PAs session at #ACC25: • More than a test—it’s a career milestone • Prep with purpose, not panic • Exam day success = strategy + mindset #Cardiology #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

Key takeaways from the CCKE for NPs & PAs session at #ACC25: • More than a test—it’s a career milestone • Prep with purpose, not panic • Exam day success = strategy + mindset #Cardiology #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

Hard to do a clinical trial during a pandemic + suboptimal adherence and contamination but good to see a focus on women!

Joshua Thornsberry@thornsberryjd.bsky.social · 2y ago

WARRIOR: A neutral trial, but key insights for women with INOCA. 🔹 2,476 enrolled (60% target) 🔹 High angina burden 🔹 SBP ≤120 mmHg may reduce angina 🔹 Future potential with ACEI/ARB + statins #ACC25 #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

WARRIOR: A neutral trial, but key insights for women with INOCA. 🔹 2,476 enrolled (60% target) 🔹 High angina burden 🔹 SBP ≤120 mmHg may reduce angina 🔹 Future potential with ACEI/ARB + statins #ACC25 #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social